» Download Public Reports
12 reports
- Company report
- April 2012
- 5 pages
July 2012
... Of the changzhou platform is cross border collaboration in pharmaceuticals, chemicals, medical devices and medical diagnostics. A team of consultants from isis undertook a programme of work in support ...
March 2012
... Diagnosis and prognosis of diseases, and to predict and monitor the response to pharmacological treatment. It is also a leader in the development of molecular diagnostic technologies. Groundbreaking ...
September 2011
... Research grants have been published to advance in the digitalization of the image non rx in dermatology, ophthalmology and electrocardiography 39 non radiology image key ict projects Medical image ...
November 2010
... The effect of sterilizing agent. The meristem tips 0.3-1.5 Mm in length were cut from nodal segments under a binocular microscope. Leaves are removed one by one until the meristem dome is visible, but still ...
January 2012
... Is specialized in the production of ready-to-use reagents for the diagnosis of infectious diseases in humans by different techniques Ranging from the trional cell culture to the most innovating ...
April 2013
... Clinics-ambulatory-care-centers-surgery-cente-market-report.Html sales and market share analysis - sales and market shares of major coagulation reagent and instrument suppliers. Current and emerging products - analysis of coagulation procedures performed in poc ...
January 2012
... The highest quality diagnostic assays at the lowest possible price backed by the best service and technical support. The company complies with the european In vitro diagnostic directive (98/79 ec). All ...
January 2013
... Like cancer. The technique works by injecting into the patient S body targeted radiopharmaceuticals that accumulate in the organs or lesions that reveal specific biochemical processes. Molecular ...
» Purchase Premium Reports
(From $ 250 - $ 12 800)
About 700 reports
- $ 12 800
- Industry report
- February 2013
- by Venture Planning Group
This new 500-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities ...
February 2013
$ 12 800
This new 450-page five-country study from Venture Planning Group presents test volume forecasts, instrument placements and installed base by manufacturer and model, as well as sales and market shares of ...
February 2013
$ 12 800
This new 820-page five-country report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...
February 2013
$ 12 800
This new 900-page five-country market intelligence and technology assessment report from Venture Planning Group will help current suppliers and potential market entrants identify and evaluate emerging ...
February 2013
$ 12 800
This new 1,600-page five-country report from Venture Planning Group is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding ...
February 2013
$ 12 800
This new 600-page five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the European blood ...
February 2013
$ 12 800
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities ...
